| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |